Inhaler use is a critical aspect of respiratory care, yet it's an area where many patients and healthcare professionals alike struggle. Liam Clutterbuck, a market access and engagement lead at Trudell Medical International, highlights a significant issue: incorrect inhaler technique can lead to medication not reaching the lungs effectively. This is a problem that affects millions, particularly those using pressurized metered dose inhalers (pMDIs), which are the most common type. The issue is not just about technique; it's about the potential for serious health consequences. Incorrect use can lead to a reduced dose of medication reaching the lungs, which can have a major impact on treatment outcomes.
What makes this particularly fascinating is the widespread nature of the problem. Up to 80% of people don't use pMDIs correctly, which means that up to four million people in the UK alone could be at risk. This isn't just a minor inconvenience; it's a critical issue that can lead to avoidable deaths. The challenge is particularly acute for certain patient groups, such as young children, the elderly, and those with muscle weakness, who may struggle to generate the required inspiratory force. In my opinion, this highlights a deeper issue: the lack of standardized prescribing and training in primary care.
One solution to this problem is the use of spacers, or valved holding chambers (VHCs). These devices temporarily hold the medication within the chamber after it is released, making it easier for patients to inhale smoothly and breathe tidally. This significantly reduces throat deposition, where medication sticks to the back of the throat rather than reaching the lungs. Despite decades of evidence supporting their use, one in ten respiratory health professionals still doesn't consistently prescribe spacers. This is a concerning trend, as it suggests that many patients are not receiving the full benefit of their medication.
What many people don't realize is that spacers are not just a technical solution; they also have social and cultural implications. Patients, especially adults, often feel uncomfortable using spacer devices around others. This is a significant barrier to their use, and it's one that needs to be addressed. In my view, this highlights a deeper issue: the need for public education to normalize spacer use. Without this, many patients will continue to struggle with their respiratory conditions, and the potential for avoidable deaths will remain.
Improving inhaler technique is not a glamorous intervention, but it may be one of the most cost-effective and impactful steps we can take to improve respiratory outcomes. By supporting improved disease control, reducing exacerbations, and ultimately preventing avoidable loss of life, we can make a real difference in the lives of those affected by respiratory conditions. From my perspective, this is a call to action for healthcare professionals and policymakers to prioritize the issue of inhaler technique and work towards improving patient outcomes.
